A conserved isoleucine maintains the inactive state of Bruton’s tyrosine kinase by Boyken, Scott E. et al.
Biochemistry, Biophysics and Molecular Biology
Publications Biochemistry, Biophysics and Molecular Biology
10-23-2014
A conserved isoleucine maintains the inactive state
of Bruton’s tyrosine kinase
Scott E. Boyken
Iowa State University
Nikita Chopra
Iowa State University
Qian Xie
Iowa State University
Raji E. Joseph
Iowa State University, jraji@iastate.edu
Thomas E. Wales
Northeastern University
See next page for additional authorsFollow this and additional works at: http://lib.dr.iastate.edu/bbmb_ag_pubs
Part of the Biochemistry Commons, Biophysics Commons, Molecular Biology Commons, and
the Structural Biology Commons
The complete bibliographic information for this item can be found at http://lib.dr.iastate.edu/
bbmb_ag_pubs/137. For information on how to cite this item, please visit http://lib.dr.iastate.edu/
howtocite.html.
This Article is brought to you for free and open access by the Biochemistry, Biophysics and Molecular Biology at Iowa State University Digital
Repository. It has been accepted for inclusion in Biochemistry, Biophysics and Molecular Biology Publications by an authorized administrator of Iowa
State University Digital Repository. For more information, please contact digirep@iastate.edu.
A conserved isoleucine maintains the inactive state of Bruton’s tyrosine
kinase
Abstract
Despite high homology among non-receptor tyrosine kinases, different kinase families employ a diverse array
of regulatory mechanisms. For example, the catalytic kinase domains of the Tec family kinases are inactive
without assembly of the adjacent regulatory domains, whereas the Src kinase domains are autoinhibited by the
assembly of similar adjacent regulatory domains. Using molecular dynamic simulations, biochemical assays,
and biophysical approaches, we have uncovered an isoleucine residue in the kinase domain of the Tec family
member Btk that, when mutated to the closely related leucine, leads to a shift in the conformational
equilibrium of the kinase domain toward the active state. The single amino acid mutation results in
measureable catalytic activity for the Btk kinase domain in the absence of the regulatory domains. We suggest
this isoleucine side chain in the Tec family kinases acts as a ‘wedge’ that restricts the conformational space
available to key regions in the kinase domain, preventing activation until the kinase domain associates with its
regulatory subunits and overcomes the energetic barrier to activation imposed by the isoleucine side chain.
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Abstract
Despite high homology among non-receptor tyrosine kinases, different kinase families employ a
diverse array of regulatory mechanisms. For example, the catalytic kinase domains of the Tec
family kinases are inactive without assembly of the adjacent regulatory domains, whereas the Src
kinase domains are autoinhibited by the assembly of similar adjacent regulatory domains. Using
molecular dynamic simulations, biochemical assays, and biophysical approaches, we have
uncovered an isoleucine residue in the kinase domain of the Tec family member Btk that, when
mutated to the closely related leucine, leads to a shift in the conformational equilibrium of the
kinase domain toward the active state. The single amino acid mutation results in measureable
catalytic activity for the Btk kinase domain in the absence of the regulatory domains. We suggest
this isoleucine side chain in the Tec family kinases acts as a ‘wedge’ that restricts the
conformational space available to key regions in the kinase domain, preventing activation until the
kinase domain associates with its regulatory subunits and overcomes the energetic barrier to
activation imposed by the isoleucine side chain.
Keywords
Tec kinase regulation; molecular dynamics; catalytic activity; active/inactive conformational
equilibrium; isoleucine/leucine
Introduction
Protein kinases transfer the γ-phosphate of ATP to the side chain of a substrate molecule,
serving as key mediators of cellular signaling pathways. Given the importance of this
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chemical modification in driving cellular responses to stimuli, kinase catalytic activity is
tightly controlled. There are well-defined, conserved structural elements that must be
appropriately assembled for catalysis, serving as hallmarks of an active kinase (Fig. 1a): the
Lys/Glu salt bridge, the Regulatory spine (R-spine) (1–4), the αC helix, and the DFG motif
(5). Phosphorylation of one or more hydroxyl-containing side chains in the activation loop
(A-loop) triggers assembly of the active kinase conformation (Fig. 1a). Specifically, the
activation loop phosphotyrosine attracts a conserved Arg in the same loop, pulling it away
from an electrostatic interaction with a conserved Glu on the αC helix. This transition
releases the αC-helix so that it switches from an ‘αC-out’ to ‘αC-in’ conformation, leading
to the short distance (<4Å) between the side chains of the conserved Glu and a conserved
Lys, forming a new electrostatic interaction characteristic of the active kinase (6). This
electrostatic switch is accompanied by assembly of the Regulatory spine residues and a
conformational shift in the DFG motif forming a hydrogen bond between the carboxylate
side chain of the aspartate (Oδ1) and the backbone amide (NH) of the glycine.
Despite the fact that this set of structural features is present in all active kinases, it is clear
that different kinases follow different regulatory rules. Striking examples are the Tec (7–10)
and Src family tyrosine kinases (11, 12); these kinase families are closely related
evolutionarily but employ opposing regulatory schemes. Tec kinase domains, even when
phosphorylated on the activation loop, are inactive, relying on direct association with
regulatory regions outside of the kinase domain to achieve activation (13–16). In contrast,
phosphorylated Src family kinase domains are fully active by themselves (17, 18), and are
inhibited by association with their regulatory domains (19, 20). This fundamental difference
suggests that there are unique structural motifs within the Tec family that ‘hold’ these kinase
domains in the inactive conformation until proper assembly with the adjacent regulatory
domains.
Here we use a combination of computational methods, biochemical assays, and biophysical
methods to identify the molecular determinants that are responsible for the ‘inactive by
default’ status of the Tec family kinases. To identify the regulatory features within the Tec
and Src family kinase domains that are responsible for the observed differences in catalytic
efficiency, we focus on two specific kinases, Btk (one of five Tec family kinases) and Lck
(one of nine Src family kinases); these specific kinases were chosen based on availability of
high-resolution crystal structures of each kinase domain in the active conformation. Our
findings point to an isoleucine residue conserved among the Tec family kinases, that acts as
a ‘wedge’ restricting the conformational space available to key regulatory elements of the
kinase domain. Removing the ‘wedge’ by mutation of isoleucine to leucine, the
corresponding residue in the Src kinases, results in increased conformational sampling and
leads to partial activation of the Tec family kinase domain in the absence of the otherwise
necessary regulatory region. Elucidating the molecular details that account for the
conformational preferences and respective activities of the Tec and Src family kinase
domains is important for fully understanding the regulatory mechanisms that govern
signaling through these kinases.
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Results
Molecular Dynamics simulations reveal differences in the conformational preferences of
Lck and Btk kinase domains
To explore the differences in the Lck and Btk kinase domains that differentially drive the
assembly of the active catalytic core, we initialized all-atom Molecular Dynamics (MD)
simulations starting from the active conformations of each kinase domain. PDB ID 3LCK
was used as the starting structure for active Lck kinase domain and PDB ID 3K54 was used
as the starting structure for active Btk kinase domain. We performed 100 ns equilibrium
simulations in the Normal Pressure Temperature (NPT) ensemble, with three replicates for
the Btk structure and two replicates for Lck. Throughout the simulations, RMSD was
monitored from the starting structure for the hallmarks of the active catalytic core, as well as
distances between specific residues involved in electrostatic interactions in and around the
active site (Figs. 1b,c and S1a). The Lck kinase domain retains its active conformation
throughout the entire 100 ns in both replicates (Fig 1b). This is consistent with a recent MD
study showing that the Src kinase domain retains the active, assembled catalytic core during
a simulation of 10 microseconds (21). In contrast, the Btk kinase domain deviates from its
starting active structure early in the simulation (Fig. 1c). Structural changes in Btk are
localized within the N-lobe of the kinase; the Btk αC helix moves away from the N-lobe,
breaking the K430-E445 salt bridge and disassembling the Regulatory-spine (Fig. 1c).
During the simulations, Btk samples inactive conformations observed in numerous Tec
family kinase domain crystal structures in which the αC helix adopts the inactive ‘αC-out’
position but the A-loop is in the active “open” position. Additionally, the observed outward
movement of the Btk αC helix led to formation of the R544/E445 salt bridge in one
replicate, a structural feature that is observed in many inactive kinase domain structures
(Fig. S1b).
Given the differences in the simulations of Btk and Lck, we set out to identify molecular
features that lead to the spontaneous conformational shift away from the active Btk kinase
domain structure. We focused on the αC helix since the most pronounced changes occur in
this region of the structure during the course of the simulation. Assessing the relative
structural stability conferred by local interactions within protein kinases has proven useful in
determining the molecular basis of cancer causing mutations that likely alter the
conformational preferences of a kinase domain (22). The hypothesis is that specific side
chains that cannot form optimal contacts within the surrounding structure will be a driving
force for conformational changes that allow for optimal interactions. Drawing an analogy to
that work, we performed mutational frustration analysis (see Methods) (23–25) at 0, 10, and
100 ns time points from the Btk simulation. A number of frustrated contacts are evident for
residues on the αC helix early in the simulation and these non-optimal contacts are resolved
as the αC helix moves to the ‘αC-out’ conformation (Fig. S2a). Four αC helix residues,
E439, E441, F442 and E445, participate in the majority of the frustrated contacts at early
time points in the simulations (Fig. S2b), indicating that these sites are likely regions of local
instability in the structure of the active Btk kinase domain. Since these frustrated αC helix
residues all face the N-lobe, we reasoned that mutation of these amino acids might relieve
the non-optimal contacts and stabilize the active, ‘αC-in’ conformation of the Btk kinase
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domain. E439 and E441 are unique to the Tec family kinases (not conserved in Src kinases)
and so these Btk residues are targets for mutagenesis to the corresponding residues in Lck
(E439P, E441A).
The other two residues on the αC helix identified by frustration analysis, F442 and E445, are
completely conserved throughout the Tec and Src family kinases and so direct mutation of
these residues was not pursued. However, the fact that these residues are at the hub of a
locally frustrated region within the active Btk kinase domain structure prompted us to
examine amino acids interacting with F442 and E445, using a contact radius of 6Å (Fig.
S2c). Excluding residues on the αC helix itself, we find that F442 and E445 are within 6 Å
of the side chains of eight different residues in the Btk kinase domain: K430, I432, V463,
T465, I470, I472, D539, and F540 (Fig. S2c). Seven of these amino acids (underlined in the
list above) are either conserved across both the Tec and Src family kinases or are present in
certain members of both families. Btk I432 is unique as it is conserved among the Tec
kinases but not present in any of the Src family kinases. In the Src kinases this residue
corresponds to either leucine or methionine. Thus, in addition to the Btk E439P and E441A
mutations, mutation of Btk I432 to a leucine (present in Lck) is also a candidate for further
characterization by in vitro kinase assays.
Mutation of isoleucine 432 to leucine relieves the inactive by default status of the Btk
kinase domain
Based on analysis of the MD simulations, three mutations (I432L, E439P, and E441A) were
introduced together and separately into the His-tagged Btk kinase domain and each protein
was expressed and purified. Btk kinase activity was first assessed by western blot to measure
autophosphorylation using a phosphotyrosine specific antibody for the phosphorylation site
(Y551) on the Btk activation loop (Fig. 2a). Activation loop phosphorylation is commonly
used as a qualitative indicator of kinase activity (26, 27). Western blot analysis indicates that
the triple mutant (Btk IEE/LPA) is more active than wild type Btk, consistent with analysis
of the Btk simulation data suggesting that I432, E439 and E441 contribute to the
destabilization of the active Btk conformation. For the separate mutations, I432L activates
Btk whereas the E439P and E441A do not (Fig. 2a). Initial velocity measurements for
phosphorylation of the poly (4:1 Glu, Tyr) peptide also show that Btk I432L is catalytically
more active than wild type Btk for this generic substrate (Fig. 2b). The 5-fold activity
increase (Vi/[Enzyme] = ~0.5 for Btk I432L and Vi/[Enzyme] = ~0.1 for isolated Btk kinase
domain) can be compared with that of full length Btk to assess the extent of activation
realized by the I432L mutation. The previously published initial velocity data for full length
Btk, Vi/[Enzyme] = 2 min−1 (14), suggests that the I432L mutation in the Btk kinase domain
activates the isolated Btk kinase domain to 25% of that of the full-length enzyme. It should
be noted here that the previously characterized full length Btk protein was expressed and
purified from insect cells rather than the bacterial expression system used here for the kinase
domain fragments.
To further characterize the I432L mutation we made use of a previously published mutant
Btk kinase domain, Btk Y617P (28). The Y617P mutation is located in the C-lobe of the
kinase domain and results in higher yield from bacteria than the wild type Btk kinase
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domain, facilitating more detailed enzymology and biophysical characterization. We have
previously noted that the Y617P mutation enhances the basal activity of the Btk kinase
domain by an unknown mechanism and so we first wished to assess whether the I432L
mutation causes the same activation in this background compared to wild type Btk kinase
domain. Using autophosphorylation of Y551 as a qualitative indicator of activity, we find
that the Btk Y617P/I432L kinase domain retains the activity enhancement over the Btk
Y617P kinase domain observed for the wild type kinase domain and I432L single mutant
(Fig. 2c). We therefore proceeded with quantitative assays to determine KM and kcat values
for the Btk Y617P kinase domain with and without the I432L mutation. Peptide substrate
curves were generated using Peptide B (aminohexanoyl biotin-EQEDEPEGIYGVLF-NH2)
and the data were fit to determine KM and kcat values for the Btk kinase domain and the
I432L mutant kinase domain (Fig. 2d). The Btk Y617P/I432L mutant kinase domain
exhibits a kcat value = 12.2±1.3 min−1, seven times faster than kcat = 1.7±0.2 min−1 for the
Btk kinase domain carrying the wildtype isoleucine at position 432. The KM value for the
Btk I432L mutant kinase domain does not change significantly from that of the Btk kinase
domain (KM(Btk Y617P) = 179 ± 40 μM; KM(Btk Y617P/I432L) = 275 ± 57 μM). To
ensure the observed activity differences are not arising due to stability differences between
Btk Y617P and Btk Y617P/I432L, we measured thermal denaturation curves for both
proteins and find that the more active Btk Y617P/I432L kinase domain is in fact slightly less
stable than Btk Y617P kinase domain (Fig. S3). The Btk kinase domain Y617P/I432L
mutant exhibits a Tm = 43 °C compared to Tm = 44.5 °C for the Btk kinase domain Y617P.
Thus, results of qualitative western blot analysis, initial velocity measurements, and peptide
phosphorylation kinetics all show that substitution of the isoleucine at position 432 with
leucine increases the catalytic activity of the isolated Btk kinase domain.
We next carried out 50 ns simulations for Btk I432L, using the same starting conformation
(3K54) and parameters as the simulations in Figure 1 (Figs. 3a, S2d). Throughout the
simulation, the Btk I432L mutant retains the hallmarks of an active kinase (Fig. 3a) to a
greater extent than the corresponding simulation of the wild type Btk kinase domain (Fig.
1c). At the end of the simulation, the leucine side chain introduced at position 432 in Btk has
rotated around the Cα-Cβ bond to adopt the trans chi1 rotamer conformation creating space
for the F442 side chain on the C-helix (Fig. 3b). The resulting ‘αC-in’ conformation appears
stabilized by favorable contacts between the F442 side chain and the side chains of L432
and I472; the latter residue is conserved in both Tec and Src kinases. The final structure
surrounding F442 in the simulation of the Btk I432L kinase domain is very similar to the
structure of the Lck kinase domain throughout its entire simulation (Fig. 3c).
This analysis of the Btk I432L mutant prompted closer inspection of the I432 rotamer
population in the wild type Btk crystal structure and simulation data. The precise position of
the isoleucine side chain atoms in the Btk kinase domain structure is uncertain due to poor
side chain electron density. The reported B-factors for this region of the structures are high,
consistent with flexibility or uncertainty in this region. We therefore used the simulation
data to monitor rotamer occupancies over time for the I432 side chain. Plotting the Btk I432
chi1 angle as a function of simulation time reveals multiple rotameric states with a
preference for the gauche(+) and gauche(−) rotamers (chi1 = ±60°) and only a transient
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occupancy of the trans rotamer (chi1 = ±180°) (Fig. 4a–c). The I432 gauche(+) chi1 angle
results in the delta methyl group (Cδ) of I432 pointing directly toward F442 on the αC helix
providing a steric block to the ‘αC-in’ conformation that is required for the active kinase
(Fig. 4b). The gauche(−) chi1 angle for I432 also places the sterically bulky isoleucine side
chain in a position that blocks F442 (Fig. 4c).
The same chi1 analysis for the corresponding leucine for both Lck (L275) and the Btk I432L
mutant, suggests that in these cases the non-beta branched leucine side chain predominantly
occupies the trans rotamer (Fig. 4d,e) as already observed at the end point of the Btk I432L
simulation (Fig. 3b). The trans leucine rotamer does not sterically block the phenylalanine
side chain on the αC helix resulting in an increase in the conformational space available to
the αC helix of Lck and Btk I432L (Fig. 4f). Moreover, L275 in the Lck kinase domain
structure has low B-factors for the side chain atoms indicating that the trans chi1 angle is a
stable conformation in the crystal.
The simulation data suggest that the steric effect of the I432 side chain on the local structure
of the Btk kinase domain N-lobe, in particular the phenylalanine on the αC-helix, is distinct
from that of the corresponding leucine in the Src family kinases. The rotameric preferences
of the beta-branched I432 side chain seem to create a wedge that limits the conformational
space available to the Btk αC helix in the isolated Btk kinase domain (Fig. 5a, left).
Mutation of Btk I432 to the non-beta-branched leucine opens the hydrophobic surface
formed by L432 and I472 (see Fig. 3b) to accommodate the side chain of F442. In a similar
manner, we suggest that the conformational preference of the native isoleucine side chain in
wild type Btk could shift to the trans chi 1 rotamer upon activation by the associated
regulatory domains of Btk, creating space for F442 and allowing the αC helix to more
readily sample the ‘αC-in’ conformation of the active kinase domain (Fig. 5a, right).
The proposed model predicts that, in full length Btk, the non-catalytic regulatory region
provides sufficient stabilization energy to overcome the intrinsic conformational preference
of the isolated kinase domain for the inactive state, presumably shifting the I432 chi1
rotamer population toward the trans conformation resulting in greater sampling of the active
conformation. To test this hypothesis, we introduced the I432L mutation into full length Btk
and compared the activity of this mutant with the non-mutated full length Btk kinase. The
activity of full length Btk and full length Btk I432L are indistinguishable by western blot
analysis probing activation loop (pY551) phosphorylation levels (Fig. 5b). In this
experiment we probed activation loop phosphorylation levels before and after incubation
with ATP to show that both proteins, when purified, start at the same (low) level of
phosphorylation on Y551. The corresponding experiment for the isolated Btk kinase domain
demonstrates the activating effect of I432L (Fig. 5c) after incubation with ATP as already
shown in Figure 2.
The I432L mutation alters the conformational equilibrium of the Btk kinase domain
To experimentally test the hypothesis that the Btk I432L mutant is more active than wild
type Btk kinase domain due to differences in the conformational space available to the αC
helix, we turned to NMR spectroscopy to measure the dynamics of residues in this region of
the Btk kinase domain. The resonance frequency of every hydrogen (1H) that is directly
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attached to a nitrogen (15N) is measured using a TROSY (transverse relaxation–optimized
spectroscopy) version of the heteronuclear single quantum correlation (HSQC) spectrum
(29). The resulting data provides a direct measure of the chemical environment and
dynamical properties of each amide NH group in the protein. Comparison of the 1H-15N
TROSY HSQC spectrum of uniformly 15N labeled Btk kinase domain with that of 15N
labeled Btk I432L reveals linewidth differences for a subset of peaks indicative of dynamic
differences in specific regions of the two proteins (Fig. 6a,b). Overall, NMR linewidths are
broader for the Btk I432L mutant than wild type Btk suggesting that the activated mutant is
more dynamic. Complete backbone resonance assignments for the Btk kinase domain are
not available and so we have pursued selective isotopic labeling to obtain chemical shift
assignments for the phenylalanine backbone amide resonances in the Btk kinase domain (27,
28).
In the present work, the amide resonance corresponding to F442 on the αC helix could not
be unequivocally assigned. Having previously assigned the backbone amide of F540 (27),
we examined its resonance in 1H-15N TROSY HSQC spectra of the Btk wild type and I432L
mutant kinase domains. The location of F540 within the conserved DFG motif places it
close in space to the αC helix (Figs. 1a) where it is likely to report on dynamic changes that
result from substitution of I432 with leucine. Indeed, a peak corresponding to F540 is
present in the 1H-15N TROSY HSQC of wild type Btk, but is absent in the spectrum of Btk
I432L, due to line broadening and/or a significant resonance frequency change, (Fig. 6a,b).
The absence of new peaks in the spectrum of Btk I432L kinase domain that are not present
in the wild type data favors line broadening to explain the disappearance of the F540 amide
resonance. The significant change in the F540 resonance combined with observation of
overall line broadening in the spectrum of Btk I432L, is consistent with an increase in
conformational exchange on the μsec or faster timescale (30) in the more active Btk I432L
mutant.
The spectral changes in the F540 amide resonance that are observed upon mutation of I432
to leucine prompted us to compare the DFG motif in simulations of wild type Btk with that
of the Btk I432L mutant. The DFG motif in all available crystal structures of the Btk kinase
domain adopts a conformation that is not optimal for an active kinase. More specifically, the
Btk 3K54 crystal structure has a DFG motif that is similar to the ‘DFG-in’ conformation, but
the carboxylate side chain of D539 (Oδ1) does not form a hydrogen bond to the backbone
amide (NH) of G541 (Fig 6c, left). Moreover, in simulations of wild type Btk kinase
domain, the distance between Oδ1 of D539 and the backbone amide nitrogen (N) of G541
varies between 6 and 8 Å suggesting that the hydrogen bond is never significantly populated
(Fig. 6c, right). In contrast, during the simulation of the Btk I432L mutant, the DFG motif
adopts a conformation in which the aspartate Oδ1 is <3.5 Å from the glycine backbone
amide (N), consistent with formation of a hydrogen bond (Fig. 6d, right). In one of the two
replicates the hydrogen bond is maintained for a significant time during the simulation while
the short distance between Oδ1 and N is only transiently populated in the other replicate. A
snapshot of the Btk I432L kinase domain during the simulation shows formation of the
Oδ1/NH hydrogen bond within the DFG motif (Fig. 6d, left). The DFG conformation
observed in the Btk I432L simulation is indistinguishable from that in the active structure of
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Lck. Thus, NMR data combined with MD simulations suggest that mutation of I432 to
leucine within Btk results in conformational sampling of the optimal ‘DFG-in’ structure
associated with the active state of protein kinases.
To further probe the dynamic characteristics of the Btk I432L mutant we compared the
solution behavior of Btk kinase domain with the Btk I432L kinase domain mutant by
hydrogen-deuterium exchange mass spectrometry (HDXMS). HDXMS allows detection of
backbone amide hydrogens for each amino acid in the protein (except proline) so that a
direct comparison of the solvent accessibility/H-bonding of the amide N-H can be made for
wild type Btk and the Btk I432L mutant. Comparison of the hydrogen exchange behavior for
Btk I432L versus wild type Btk showed measurable changes in deuterium incorporation in
the kinase domain for the I432L mutant (Fig. 7a, Fig. S4). Most of the changes in deuterium
exchange are localized in the N-lobe of the kinase, with the C-lobe remaining relatively
unperturbed. The largest differences in deuterium uptake are observed in peptides that cover
the β2 strand, the β2-β3 loop, and the N-terminal end of the activation loop in the Btk I432L
mutant compared to wild-type Btk (Fig. 7a,b). For these regions of secondary structure, the
Btk I432L mutant exchanges more readily than wild type Btk suggesting the mutant protein
samples more open conformations than wild type Btk. The Btk I432L mutant also shows
small differences in deuterium uptake for part of the β3 strand, β4 strand, β4-β5 loop, β5
strand, β6 strand, β6-β7 loop, β7 strand (including the DFG motif), the catalytic loop and the
C-terminal end of the activation segment (Fig. 7b,c,d). In these peptide regions as well, Btk
I432L showed increased deuterium incorporation, although more moderate, when compared
to wild type Btk. It is also interesting to note that hydrogen/deuterium exchange does not
differ between the two proteins for the αC helix itself suggesting that amide hydrogen
accessibility within this region of secondary structure is not affected by the mutation. Thus,
to the extent that the αC helix samples greater conformational space in the Btk I432L
mutant, it does so in a concerted fashion without changes to the helical structure.
Discussion
Leucine and isoleucine are structural isomers that are often considered interchangeable due
to their related hydrophobic side chains (31, 32). At the same time, it is appreciated that the
beta-branched isoleucine side chain introduces conformational restrictions that can either
stabilize or destabilize the polypeptide chain depending upon context (33). For Btk and the
Tec family kinases, MD simulation data suggest that specific chi 1 rotamers of the
isoleucine at position 432 in the kinase domain sterically maintains the inactive kinase
domain conformation (αC helix out) in the absence of the Btk regulatory domains. Mutation
of the I432 to the non-beta branched leucine likely shifts the rotamer preference at this
position leading to changes in protein motions and an increase in activity for the isolated Btk
kinase domain. Indeed, the I432L mutation selectively affects kcat and not KM consistent
with the notion that this mutation allows the Btk kinase domain to more frequently sample
the active state.
In the full length Btk kinase, assembly of the non-catalytic regulatory domains onto the Btk
kinase domain shift the conformational preference of the kinase domain to the active state,
superseding the effects of the leucine substitution that are evident in the isolated kinase
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domain. Presumably, in the controlled signaling pathways of Btk, negative regulatory
signals would promote release of the Btk kinase domain from interactions with the
regulatory domains, leading to a conformational shift in the kinase domain toward the
inactive state. The shift from active to inactive state is driven in part by the conformational
preferences of the I432 side chain within the released Btk kinase domain.
Mutations that favor the ‘αC-in’ conformation of any kinase could result in hyperactivation.
Mutation of F457 (corresponds to F442 in Btk) to leucine in the Tec family kinase Bmx is
reported in the Catalogue of Somatic Mutations in Cancer (COSMIC) database (34, 35). The
phenylalanine to leucine mutation changes the face of the αC helix in Bmx and the less
sterically demanding leucine side chain may pack more favorably with the isoleucine in
Bmx (I447) leading to increased catalytic activity of the Bmx F457L kinase domain. Along
these lines, it is also interesting to note that a leucine to phenylalanine mutation at the
position corresponding to Btk I432 within the B-Raf kinase (L485F) is reported in the
COSMIC database. Given the conserved phenylalanine on the αC helix (B-Raf F498
corresponding to F442 in Btk) it is tempting to speculate that a phenylalanine in place of
leucine on the β3 strand of B-Raf might form favorable pi stacking interactions with F498
on the αC helix stabilizing the active ‘αC-in’ conformation. These reports collectively
suggest that side chain packing in the region defined in this study can have significant
effects on kinase catalytic activity. These effects may not be limited to kinases, as activity
changes due to mutation of isoleucine to leucine have been characterized for several non-
kinase systems (36–38). In one example, the human prolactin receptor is activated by
mutation of an isoleucine to leucine resulting in dynamical changes and stabilization of the
active state (39).
Both NMR spectroscopy and HDXMS support a model in which the Btk kinase domain
experiences greater dynamic flexibility in the active state compared to the inactive state. The
increase in deuterium incorporation suggests that the Btk I432L protein samples more open
conformations than the wild type Btk kinase domain. NMR analysis of the phenylalanine in
the DFG motif of Btk (F540) reveals differences in the relaxation properties of this residue
in the context of Btk wild type versus Btk I432L. Given the proximity of the DFG motif to
the αC helix, the observed increase in exchange broadening for the backbone amide of F540
in Btk I432L may reflect the nearby αC helix sampling greater conformational space that
includes the ‘αC-in’ conformation associated with the kinase active state. In view of the
well-characterized conformational shift of the DFG motif between active and inactive kinase
structures (3), it is tempting to speculate that the slower conformational fluctuations on the
microsecond timescale within Btk I432L evident in the NMR data may reflect exchange
between DFG conformations. Along these lines, it is interesting to note that the optimal
‘DFG-in’ state is not observed in the crystal structures of Btk, perhaps another consequence
of destabilization of the active state by I432. Indeed, the importance of the interplay between
the DFG motif, the regulatory spine (which includes the DFG phenylalanine) and the
stability of the active kinase has been recently addressed in related work on PKA (40) and
together these findings emphasize the importance of the DFG phenylalanine in the
assembled regulatory spine. Finally, the microsecond time scale motions detected for the
DFG motif in the more active form of Btk (I432L) may also contribute directly to catalysis
as has been suggested for other systems (41–43).
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The increasing power of molecular dynamics simulations coupled with experiment offers a
promising approach to elucidate the molecular determinants that control enzyme activity and
regulation (21, 44). Our combined use of computation and experiment suggests that a single,
conserved isoleucine residue is at least partly responsible for keeping Tec family kinase
domains inactive until upstream signaling events trigger association between the non-
catalytic regulatory region and kinase domain (14). Future work will aim to elucidate yet
unidentified sequence and/or structural features that cooperate with the isoleucine 432 to
drive the conformational equilibrium of the Tec family kinase domains toward the inactive
state in the absence of the non-catalytic regulatory domains. A full mechanistic
understanding of how the conformational equilibrium of the Tec kinase domains is
controlled may lead to new opportunities in kinase inhibitor development. Additionally, the
structural features exploited by the Btk kinase domain to favor the inactive conformation
could provide clues and/or inspiration in drug discovery efforts aimed at inhibiting kinase
domains that, unlike Btk, are active by default.
Materials and Methods
Structure preparation for simulations
Initial coordinates were obtained from the Protein Data Bank (PDB): 3K54 for active Btk
kinase domain, and 3LCK for active Lck kinase domain. The starting structures consisted of
the single kinase domains in the apo state (absent ATP or inhibitor), corresponding to aa
396–659 for Btk, and aa 239–501 for Lck. Both 3K54 and 3LCK contain a linker region N-
terminal to the kinase domain that has been removed in order to monitor the effects of the
isolated kinase domains and ensure identical domain boundaries for direct comparison of
Btk to Lck. Regions missing from the electron density maps were modeled using
MODELLER (45) and related active kinase domain structures as templates (see details in
Supplemental Data). In all of the simulation systems, the kinase domains were
phosphorylated, using the phosphotyrosine patch TP2, at the Tyr residue of the activation
loop (Y551-Btk, Y394-Lck) to reflect the physiological state of the active kinase. The 3LCK
crystal structure is phosphorylated at this position and the 3K54 crystal structure contains
the Y551E phosphomimetic mutation at this position that was changed in silico to pY551.
The I432L mutant structure was generated using MODELLER (45) and SCWRL 4(46).
Simulation setup
All-atom Molecular Dynamics simulations were performed using the CHARMM27(47)
force field and TIP3P explicit water model in the NAMD 2.8 program (48). The simulation
systems were solvated in a periodic water box with 15 Å buffering distance between protein
surface and the box. Na+ and Cl− ions were added to neutralize the charge of the system,
with a final molar concentration of approximately 150mM. Systems were equilibrated and
simulated in the NPT ensemble at 310 K and 1 atm, using Particle-Mesh Ewald for long-
range electrostatics. The cutoff used for the van der Waals and short-range electrostatics
calculations was 12 Å and covalent hydrogens were kept rigid using the ShakeH algorithm.
The simulation systems consisted of ~51000 atoms. The time step used was 2 fs. Simulation
systems were first minimized (20 picoseconds (ps)) and equilibrated (50 ps) holding the
protein rigid, allowing water molecules and Na+ and Cl− ions to move. The modeled loops
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were then subjected to a short minimization to remove steric clashes. Next, the entire system
was minimized, gradually releasing harmonic constraints on all protein heavy-atoms. The
temperature of the system was then raised from 200 K to 310 K (5 K increments over 90 ps)
with harmonic constraints on all protein heavy-atoms. Subsequently, the harmonic
constraints were gradually released and the system was equilibrated for a total time of
approximately 1 ns before starting production runs for analysis.
Analysis of simulation trajectories
Analysis of MD trajectories was carried out using VMD (49) and MATLAB (The
Mathworks, Inc.). For RMSD calculations, superposition was based on the backbone atoms
of the C-lobe, which in all simulations showed minimal movement, using the minimized
starting structure for that simulation as the reference. Salt bridge distances were measured in
VMD using the distance between the center of mass of the oxygens in the negatively
charged side chain and the center of mass of the nitrogen in the positively charged side
chain. Snapshots at 10 ns intervals were submitted to the Frustratometer server (50) (25).
Mutational frustration scores, both pairwise and single-residue, were extracted from this
analysis and used to identify frustrated residues. A Frustration Index (or z-score) ≥ 0.78 is
minimally frustrated and < −1.0 is highly frustrated. Figures were generated using PyMOL
(51).
Protein Expression, Purification and in vitro kinase assays
Btk mutants were generated by site-directed mutagenesis (Quikchange II kit, Stratagene).
All constructs were confirmed by sequencing at the Iowa State University DNA synthesis
and sequencing facility. His6-tagged Btk (residues 369–659) kinase domains (wild type and
mutants used for Fig. 2a & b) are expressed in Arctic Express BL21(DE3) cells (Stratagene).
Btk constructs (both kinase domain fragment and full length) containing the previously
described Y617P mutation (28) are expressed in BL21(DE3) cells. Proteins used for
enzymatic analysis and NMR spectroscopy are purified as previously described (52). Full
length Btk Y617P and Btk Y617P/I432L are co-expressed with YopH to improve expression
yield. Proteins used for HDXMS were further purified on a Hiload 75 (GE Healthcare) gel
filtration column, concentrated to 80 μM, snap frozen in 100 μL aliquots and stored at −80
°C.
Kinase assays were performed as in Joseph et al. (15) using either wild type Btk kinase
domain and the corresponding Btk mutants (I432L, E439P, E441A, and IEE/LPA) or Btk
kinase domain Y617P and the corresponding Btk Y617/I432L mutant as indicated. Kinase
reactions were carried out using 300 nM enzyme and analyzed by western blot and activity
detected with anti-Btk pY551 antibody (BD Biosciences). Kinase assays involving the poly
(4:1 Glu, Tyr) peptide substrate were carried out at room temperature by incubating the
enzyme in a reaction buffer of 50 mM Hepes (pH 7.0), 10 mM MgCl2, 1 mM dithiothreitol
(DTT), 1 mg/mL bovine serum albumin (BSA), 1 mM Pefabloc, 5 mCi 32P-ATP, 5 mg/ml
poly (4:1 Glu, Tyr) peptide (Sigma) and 200 μM ATP. The peptide substrate was captured
on a P-81 membrane (Whatman), washed thrice with 0.1% Phosphoric acid, once with 70%
ethanol, dried and counted by scintillation counting. Full-length Btk enzymes and Btk kinase
domains used in the kinase assays shown in Figure 5 are co-expressed with YopH to
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eliminate activation loop phosphorylation prior to initiating the kinase assay (53). As a
result, kinase assays using proteins produced in this way include the phosphatase inhibitor,
sodium orthovanadate (1 mM). Kinetic parameters for Btk kinase domain Y617P and Btk
kinase domain Y617P/I432L are derived using radioactive assays as follows: 1 μM Btk
kinase domain Y617P or Y617PI432L mutant was incubated with peptide B substrate
(aminohexanoyl biotin-EQEDEPEGIYGVLF-NH2, a previously identified Tec family
kinase substrate (16)). Peptide concentrations ranged from 0–550 μM in the reaction buffer
(50 mM HEPES pH 7.0, 10 mM MgCl2, 1 mM DTT, 1 mg/ml bovine serum albumin, 1 mM
Pefabloc, 200 μM ATP and 5 μCi of [32P]ATP (Perkin Elmer)) at room temperature. At 10-
min and 20-min reaction times, 10 μl of the reaction mixture was removed and mixed with 5
μl of 8M guanidine hydrochloride to terminate the reaction. 10 μl of this reaction mixture
was then spotted onto the biotin capture membrane (Promega), washed and the radioactivity
incorporated on the peptide B substrate was quantified by scintillation counting. Each assay
was performed in duplicate. The initial velocity of phosphorylation was then derived and
KM and kcat values were obtained from fitting the data to the Michaelis Menten equation
using GraFit.
NMR spectroscopy
Uniformly 15N-labeled isolated kinase domains of Btk wild type or Btk I432L (both
containing the Y617P mutation) were produced in E. coli BL21(DE3) cells, as described
previously (28). 15N-Phenylalanine labeled samples were produced by growing the E. coli
BL21(DE3) cells in modified minimal media as described (28). The purified proteins were
concentrated and dialyzed into buffer consisting of 50 mM Bicine (pH 8.0), 75 mM NaCl, 2
mM DTT, 5% glycerol and 0.02% NaN3. All NMR spectra were collected at 298 K on a
Bruker AVII 700 spectrometer equipped with a 5-mm HCN z-gradient cryoprobe operating
at a 1H frequency of 700.13 MHz. All data were analyzed with NMRViewJ software (54).
Hydrogen/deuterium exchange mass spectrometry (HDXMS)
Btk kinase domain samples for HDXMS contain a Y551F mutation on the kinase activation
loop to prevent complications in the analysis due to differential phosphorylation. Deuterium
labeling was initiated with an 18-fold dilution of an aliquot (80 pmoles) of Btk wild type and
Btk I432L (both containing Y617P) into a buffer containing 99.9 % D2O, 20 mM Tris,
150mM NaCl, 10% glycerol, pD 8.01. The labeling reaction was quenched with the addition
of an equal volume of quench buffer [150 mM potassium phosphate (pH 2.47)]. Quenched
samples were immediately frozen on dry ice until required for liquid chromatography-mass
spectrometry (LC-MS) analysis. Quenched samples were rapidly thawed and injected into a
Waters nanoACQUITY with HDX technology (55) for online pepsin digestion and ultra
performance liquid chromatography (UPLC) separation of the resulting peptic peptides, and
analyzed as reported previously (56). All mass spectra were acquired with a WATERS
SYNAPT G2 HDMS mass spectrometer. The data were analyzed with DynamX 2.0
software. Relative deuterium amounts for each peptide were calculated by subtracting the
average mass of the undeuterated control sample from that of the deuterium-labeled sample
for isotopic distributions corresponding to the +1, +2, or +3 charge state of each peptide.
The data were not corrected for back exchange and are therefore reported as relative values
(57, 58). Differences larger than 0.4 Da are considered subtle while those larger than 0.8 Da
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are considered obvious, according to the statistical criteria for relative HDXMS
measurements previously described (59).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Tec family kinases mediate the immune response and contain catalytic domains
that are inactive by default.
• Molecular dynamics simulations identify an isoleucine in the N-lobe that
maintains the inactive state of the Btk kinase.
• Conservative mutation of isoleucine to leucine abolishes the ‘inactive by
default’ status of the Btk kinase domain.
• Unique conformational requirements of the beta-branched isoleucine side chain
create a wedge that sterically prevents sampling of the active state; mutation to a
leucine side chain removes the steric impediment, allowing increased population
of the active conformation.
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Figure 1. Molecular dynamics simulations reveal differences between the Btk and Lck kinase
domains
(a) Structure of a kinase domain in the active conformation. Key structural motifs that
stabilize the active state are indicated. The regulatory spine residues are orange and
indicated with the dotted line, the DFG motif and conserved Lys/Glu salt bridge are circled,
the αC helix is in the αC-in conformation, and the activation loop tyrosine is phosphorylated
(pY) and contacting the conserved arginine. (b) 100 nanosecond (ns) equilibrium
simulations were performed for (b) active Lck (PDB ID: 3LCK; residues 239–501) and (c)
active Btk (PDB ID: 3K54; residues 396–659). Root mean square deviation (RMSD) from
the starting structure is reported for select regions of each kinase domain: the amino-
terminal lobe (N-lobe), the carboxy-terminal lobe (C-lobe), the regulatory spine (R-spine),
and the αC helix. The distance (Å) between the lysine/glutamate side chains (K273/E288 for
Lck and K430/E445 for Btk) are shown over the course of the simulations. Replica 1 is
shown in black, 2 in dark gray, and 3 in light gray. Snapshots of the catalytic core during the
simulations from replica 1 of Lck and replica 1 of Btk are shown at 0ns, 10ns, 20ns, 30ns,
40ns, 50ns, and 100ns. For each structural superposition the lysine and glutamate side chains
are red and blue, respectively, the regulatory spine residues are orange and the αC helix and
F helix are labeled.
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Figure 2. Mutation of I432 to leucine relieves the ‘inactive by default’ status of the Btk kinase
domain
(a) In vitro kinase assays for His6-tagged Btk kinase domain variants: wild type (WT) Btk
kinase domain, three single Btk kinase domain mutants: Btk I432L, Btk E439P, and Btk
E441A, and the Btk kinase domain triple mutant: Btk IEE/LPA (I432L/E439P/E441A). Btk
activity is monitored by autophosphorylation using the anti-phosphotyrosine antibody, anti-
pY551, that is specific for phosphorylation on the activation loop (pY551) of Btk. Tyrosine
phosphorylation levels were quantified and normalized to total protein in each lane (pY551
for wild type Btk kinase is set to 1). In (a)–(d), KD refers to the isolated Btk kinase domain.
(b) Initial velocity measurements for wild type Btk kinase domain (Btk WT) and the Btk
I432L kinase domain mutant (Btk I432L) using the poly (4:1 Glu, Tyr) peptide substrate. (c)
Same experiment as shown in panel (a) comparing autophosphorylation of Btk kinase
domain Y617P and Btk kinase domain Y617P/I432L following overnight incubation with
ATP. Coomassie staining is used to show enzyme levels. (d) Peptide substrate curves for
Btk kinase domain Y617P (circles) and Btk kinase domain Y617P/I432L (squares), were fit
to the Michaelis-Menten equation using GraphFit to obtain kinetic parameters.
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Figure 3. Btk I432L behaves like Lck kinase domain in MD simulations
(a) 50 nanosecond (ns) equilibrium simulations were performed for Btk I432L. Root mean
square deviation (RMSD) from the starting structure is reported for select regions of the
kinase domain as in Figure 1b and c. Replica 1 is shown in black, replica 2 in dark gray.
(b,c) Snapshots of the 0 and 50 ns time-points from the simulation of Btk I432L (b) and wild
type Lck (c). The side chains for the phenylalanine on the αC helix (F442 for Btk, F285 for
Lck) and adjacent to the αC helix (I314 (Lck), L275 (Lck) and I472 (Btk)) are shown in red
and labeled. The site of mutation in Btk is labeled as I432L and the side chain in the
structure is the non-native leucine. The chi1 dihedral angle is defined by N-Cα-Cβ-Cγ for
leucine (N-Cα-Cβ-Cγ1 for isoleucine).
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Figure 4. Isoleucine and leucine side chain rotamer preferences differ between wild type Btk and
the Btk I432L mutant
(a) I432 chi1 angles are shown during the Btk kinase domain simulation. Gauche(+) and
gauche(−) are indicated at +60° and −60°, respectively. The preference for gauche(+) and
gauche(−) in the Btk simulations is consistent with the probabilities of isoleucine rotamers
observed in analyses of rotamer libraries (60). (b,c) Newman projections for each isoleucine
chi1 rotamer are shown above snapshots from the simulations showing I432 in the
gauche(+) rotamer conformation (b) and the gauche(−) rotamer conformation (c). (d,e) Chi1
angles for (d) L275 of Lck and (e) L432 of the Btk I432L mutant shown over the course of
the simulation. Chi1 angles shown are from a single replicate and are representative of all
simulations for each protein. (f) Newman projection for the trans leucine chi1 rotamer is
shown above the crystal structure of the Lck kinase domain (3LCK) showing the trans
rotamer for L275.
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Figure 5. Isoleucine 432 in the Btk kinase domain sterically blocks the αC-in conformation
associated with the active kinase domain
(a) Model describing the proposed steric wedge created by specific rotamer conformations
of I432 in the isolated Btk kinase domain. In inactive Btk, the αC helix samples a smaller
range of conformations that favor αC-out (small grey doubled headed arrow). The
intermediate state indicates that the putative steric block created by I432 can be relieved
either by mutation to leucine (favoring the trans rotamer) or by a shift to the isoleucine trans
chi1 rotamer (indicated by black arrow). The rotamer shift for the I432 side chain may be
energetically favored by association of the Btk regulatory domains with the N-lobe of the
kinase domain. In the active state, the αC helix samples greater conformational space
including the αC-in conformation (large grey doubled headed arrow). (b & c) Comparison
of (b) full length Btk (Btk FL Y617P) and full length Btk containing the I432L mutation
(Btk FL Y617P/I432L) and (c) isolated Btk kinase domain (Btk KD Y617P) and isolated
Btk kinase domain containing the I432L mutation (Btk KD Y617P/I432L). In both
experiments the top panel shows activation loop phosphorylation levels (pY551) prior to
incubation with ATP and the middle panel shows pY551 levels after incubation with ATP.
Bottom panel shows enzyme levels.
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Figure 6. NMR spectroscopy and simulation data suggest differences in the DFG motif between
wild type Btk and the Btk I432L mutant
(a) 1H-15N TROSY HSQC spectrum of uniformly 15N labeled Btk kinase domain. The
amide resonance for F540 is labeled in the complete spectrum and labeled in the region of
the spectrum shown in the insert. (b) 1H-15N TROSY HSQC spectrum of uniformly 15N
labeled Btk I432L kinase domain. In this spectrum, the resonance for F540 is not detected
(red box indicates expected position of the F540 amide peak; no new peaks appear
suggesting line broadening rather than a change in chemical shift). (c) Left, Structure of the
DFG motif in the Btk crystal structure. The side chains of D539, F540 and G541 are labeled
and the carboxylate of the D539 side chain and the NH group of G541 are circled. Right,
The distance (Å) between the carboxylate oxygen (Oδ1) of D539 and the amide nitrogen (N)
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of G541 is plotted for the three replicates of the 100 ns Btk simulations. (d) Left, Structural
snapshot from the Btk I432L simulation showing the conformation of the DFG motif at 36
ns. The short distance (3.2 Å) between D539 Oδ1 and G541 N is shown with a dotted line.
Right, Same as described for (c) showing the D539 Oδ1 - G541 N distance for two replicates
of the 50 ns Btk I432L simulations.
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Figure 7. Hydrogen/deuterium exchange mass spectrometry (HDXMS) indicates increased
conformational flexibility in the active Btk I432L mutant
(a) HDXMS results are illustrated on the structure of the Btk kinase domain. The Btk
structure used here is the inactive conformation (3GEN) since the activation loop is visible
in this structure. Increased deuterium uptake is seen in the Btk I432L mutant for regions
shown in red (greater than 0.8 Da increase in mass), and orange (0.5 to 0.8 Da increase in
mass). The side chains of I432 and Y551 (phosphorylation site on the activation loop) are
labeled and colored cyan. (b–d) Deuterium exchange was measured for the WT Btk kinase
domain (blue squares) and Btk I432L (red circles) and data were plotted as relative
deuterium incorporation versus time for peptides covering specific regions of secondary
structure within the N-lobe (b), DFG motif (c), and the N-terminus and C-terminus of the
Btk activation segment (d). The data are an average of two independent labeling replicates.
Error bars shown indicate the absolute range of relative deuterium level and in most cases
are within the size of the data point.
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